Menu

Image of the Day: Malaria Hologram

Optical engineers have developed a portable field microscope that could aid the diagnosis of diseased cells.

Nov 5, 2017
The Scientist Staff, The Scientist Staff

Holographic microscope image depicting the differences between healthy human red blood cells (top row) and malaria-infected cells (bottom row)BAHRAM JAVIDI, UNIVERSITY OF CONNECTICUTResearchers at the University of Connecticut have developed a portable holographic microscope that could become a reliable tool for diagnosing diseased cells. 

The device could help medical workers in Africa and Asia identify patients suffering from malaria, where, there is often little access to necessary equipment for laboratory analysis of a blood sample in remote areas. Abnormalities in red blood cells formed by the malaria-causing parasite Plasmodium falciparum cause light to pass through them differently. The new microscope detects these nanoscale differences and is capable of visualizing them, whereas conventional light microscopes have limited ability to do so. The holograms created by the microscope could also be used for rapid analysis of cell abnormalities associated with sickle cell disease, HIV, and cancer.  

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.